Tempest Therapeutics, Inc. TPST
Set alert
0.48 USD +0.01 +1.53%
As of Nov 3, 11:54 AM ET
0.4713 Day range 0.4999
0.47 52-week range 10.33
- YTD
- -83.30%
- 1 year
- -95.22%
- Open
- 0.4965
- Prev close
- 0.472
- Mkt cap
- 9.58M
- Vol
- 88.25K
- Avg vol
- 2.58M
- EPS
- -3.93
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.4713
- High
- 0.4999
- Forward P/E
- -0.61
- Beta
- -2.78
- Short ratio
- 0.39
- Inst. own
- 23.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.95482
- 200-d avg
- 2.12
- 1y target
- 18.75
Analyst view
Consensus: buy
Buy
Price target (mean) 18.75 +3812.8% upside
Now 0.4792
- Target (low)
- 5.00
- Target (mean)
- 18.75
- Target (high)
- 47.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy3
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.245 | -0.30 – -0.19 | -0.34 | +27.9% | 0 | 0.0% | 4 |
| Next quarter | -0.28 | -0.31 – -0.25 | -0.36 | +22.2% | 0 | 0.0% | 2 |
| Current year | -1.32 | -1.45 – -1.18 | -1.91 | +31.1% | 0 | 0.0% | 4 |
| Next year | -1.10 | -1.45 – -0.87 | -1.32 | +16.4% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 21, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jun 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2024 | Scotiabank | Initiated | — | Sector Outperform |
| Mar 13, 2024 | Scotiabank | Initiated | — | Sector Outperform |
| Mar 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 8, 2024 | Jefferies | Initiated | — | Buy |
| Oct 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 28, 2023 | Ladenburg Thalmann | Maintained | — | Buy |
| Mar 23, 2023 | Piper Sandler | Maintained | — | Overweight |
| Mar 23, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 8, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 15, 2022 | Ladenburg Thalmann | Initiated | — | Buy |
| May 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 21, 2021 | William Blair | Initiated | — | Outperform |
| Jul 13, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 6, 2021 | Piper Sandler | Initiated | — | Overweight |
